File:Monoclonal antibodies used in the treatment of non small cell lung cancer and their mechanism of action.webp

Page contents not supported in other languages.
Daga Wikipedia, Insakulofidiya ta kyauta.

Monoclonal_antibodies_used_in_the_treatment_of_non_small_cell_lung_cancer_and_their_mechanism_of_action.webp ‎(pikisal 550 × 354, girman fayil: 23 KB, irin MIME: image/webp)

Wannan hoto yazo daga Wikimedia Commons kuma za'a iya amfani dashi a wasu projects. Anan kasa an nuna asalin bayanin shi

Taƙaici

Bayani
English: Non-small cell lung cancer (NSCLC) cells expressing programmed death-ligand 1 (PD-L1) could interact with programmed death receptor 1 (PD-1) expressed on the surface of T cells, and result in decreased tumor cell kill by the immune system. Atezolizumab is an anti PD-L1 monoclonal antibody. Nivolumab and Pembrolizumab are anti PD-1 monoclonal antibodies. Ipilimumab is a monoclonal antibody that targets Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of T cells. Bevacizumab is a monoclonal antibody that targets Vascular Endothelial Growth Factor (VEGF) in the circulation and functions as an angiogenesis inhibitor. First line Immunotherapy for Non-Small Cell Lung Cancer. Nasser NJ, Gorenberg M, Agbarya A. Pharmaceuticals (Basel). 2020 Nov 8;13(11):373. https://doi.org/10.3390/ph13110373
Rana
Masomi

First line Immunotherapy for Non-Small Cell Lung Cancer. Nasser NJ, Gorenberg M, Agbarya A. Pharmaceuticals (Basel). 2020 Nov 8;13(11):373.

https://doi.org/10.3390/ph13110373
Marubucin

First line Immunotherapy for Non-Small Cell Lung Cancer. Nasser NJ, Gorenberg M, Agbarya A.

Pharmaceuticals (Basel). 2020 Nov 8;13(11):373. doi: 10.3390/ph13110373.

Lasisi

w:en:Creative Commons
Jinginarwa
This file is licensed under the Creative Commons Attribution 4.0 International license.
Za ka iya:
  • a raba – dan kwafa, yadawa da aika aikin
  • dan maimaita – dan daukar aikin
A karkashin wannan sharuddan
  • Jinginarwa – Dole ku bada jinjina da ta dace, samar da linki zuwa lasisin, da kuma bayyana ko kunyi sauyi. Zaku iya haka ta yadda ta dace, amma ba kowace hanya ba wanda zai nuna mai-lasisin yana goyon bayan ku ba ko goyon bayan amfanin da kuke yi ba.

Take

Add a one-line explanation of what this file represents
Monoclonal antibodies used in the treatment of non small cell lung cancer and their mechanism of action. https://doi.org/10.3390/ph13110373

Abubuwan da aka nuna a cikin wannan fayil

depicts Turanci

copyright status Turanci

copyrighted Turanci

farawa

8 Nuwamba 2020

Tarihin fayil

Ku latsa rana/lokaci ku ga fayil yadda yake a wannan lokaci

Rana/LokaciWadar sufaKusurwowiMa'aikaciBahasi
na yanzu04:17, 10 Disamba 2020Wadar sufa ta zubin 04:17, 10 Disamba 2020550 × 354 (23 KB)SannecolaUploaded a work by First line Immunotherapy for Non-Small Cell Lung Cancer. Nasser NJ, Gorenberg M, Agbarya A. Pharmaceuticals (Basel). 2020 Nov 8;13(11):373. doi: 10.3390/ph13110373. from First line Immunotherapy for Non-Small Cell Lung Cancer. Nasser NJ, Gorenberg M, Agbarya A. Pharmaceuticals (Basel). 2020 Nov 8;13(11):373. https://doi.org/10.3390/ph13110373 with UploadWizard

Wadannan shafi na amfani wannan fayil:

Amfanin fayil a ko'ina

Wadannan sauran wikis suna amfani da fayil din anan

Daga "https://ha.wikipedia.org/wiki/File:Monoclonal_antibodies_used_in_the_treatment_of_non_small_cell_lung_cancer_and_their_mechanism_of_action.webp"